|
SLC16A1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.266400E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.949600E-01 |
| Normal-vs-Stage2 |
5.972200E-01 |
| Normal-vs-Stage3 |
6.100300E-02 |
| Normal-vs-Stage4 |
1.876210E-01 |
| Stage1-vs-Stage2 |
2.834000E-01 |
| Stage1-vs-Stage3 |
1.922020E-02 |
| Stage1-vs-Stage4 |
4.517600E-02 |
| Stage2-vs-Stage3 |
1.990450E-01 |
| Stage2-vs-Stage4 |
2.890600E-01 |
| Stage3-vs-Stage4 |
9.572400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.928400E-01 |
| Normal-vs-AfricanAmerican |
2.781400E-01 |
| Normal-vs-Asian |
4.103000E-01 |
| Caucasian-vs-AfricanAmerican |
1.037780E-01 |
| Caucasian-vs-Asian |
3.632000E-01 |
| AfricanAmerican-vs-Asian |
3.617800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.980360E-01 |
| Normal-vs-Female |
3.443700E-02 |
| Male-vs-Female |
1.515110E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.232800E-01 |
| Normal-vs-Extreme_Weight |
1.861420E-01 |
| Normal-vs-Obese |
9.223600E-01 |
| Normal-vs-Extreme_Obese |
7.204400E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.215600E-02 |
| Normal_Weight-vs-Obese |
2.626200E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.900600E-01 |
| Extreme_Weight-vs-Obese |
1.819650E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.932400E-01 |
| Obese-vs-Extreme_Obese |
6.640400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.721000E-01 |
| Normal-vs-Age(41-60Yrs) |
6.679600E-01 |
| Normal-vs-Age(61-80Yrs) |
3.323800E-01 |
| Normal-vs-Age(81-100Yrs) |
4.045200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.366800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.785800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.690640E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.647630E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.261000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.862200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.196900E-04 |
| Normal-VS-Type2 PRCC |
6.998500E-03 |
| Normal-VS-KIRP CIMP |
7.181000E-01 |
| Normal-VS-Unclassified PRCC |
2.270800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.95589999996137E-06 |
| Type1 PRCC-VS-KIRP CIMP |
2.586000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
9.69309999999668E-05 |
| Type2 PRCC-VS-KIRP CIMP |
4.291200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
8.696000E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
9.569000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.600380E-01 |
| Normal-vs-N1 |
4.121600E-02 |
| Normal-vs-N2 |
1.785250E-01 |
| N0-vs-N1 |
1.597230E-01 |
| N0-vs-N2 |
9.534300E-02 |
| N1-vs-N2 |
7.194400E-01 |
|
|
